STOCK TITAN

Destination XL Group, Inc. to Review Unsolicited Tender Offer From Zodiac Partners II

(Moderate)
(Positive)
Tags

Destination XL Group (NASDAQ: DXLG) is reviewing an unsolicited $0.82 per share cash tender offer from Zodiac Partners II, announced May 12, 2026.

The board, working with independent financial and legal advisors and considering its existing merger agreement with FullBeauty, advises shareholders to take no action until it issues a recommendation via a Schedule 14D-9 filing within ten business days.

Loading...
Loading translation...

Positive

  • Unsolicited $0.82 per share cash tender offer from Zodiac Partners II
  • Board engaging independent financial and legal advisors to evaluate offer
  • Commitment to provide formal recommendation via Schedule 14D-9 within ten business days

Negative

  • None.

News Market Reaction – DXLG

+5.56%
5 alerts
+5.56% Session close to close
+12.7% Peak in 3 hr 26 min
$45.10M Market Cap
1.2x Rel. Volume

In the May 22 session, DXLG gained 5.56%, reflecting a notable positive market reaction. Argus tracked a peak move of +12.7% during that session. Our momentum scanner triggered 5 alerts that day, indicating moderate trading interest and price volatility.

Data tracked by StockTitan Argus on the day of publication.

Market Context

The stock moved +5.6% in the session following this news. A strong positive reaction aligns with the...
Analysis

The stock moved +5.6% in the session following this news. A strong positive reaction aligns with the presence of a clearly defined cash consideration of $0.82 per share and the strategic context of an existing merger agreement with FullBeauty. Historically, DXL often reacted negatively to weaker operating updates, so a sharp gain on a competing tender could reflect rerating to the offer terms. Investors would still have monitored deal certainty, regulatory filings, and Board recommendations as potential catalysts for future reassessments.

Key Figures

Tender offer price: $0.82 per share Share price pre-news: $0.701 Market capitalization: $38,789,399 +5 more
8 metrics
Tender offer price $0.82 per share Unsolicited cash tender offer by Zodiac Partners II, LLC on May 12, 2026
Share price pre-news $0.701 Last recorded price before this announcement
Market capitalization $38,789,399 Equity value prior to Board’s tender offer review statement
Q4 2025 sales $112.1M Fiscal 2025 fourth quarter results reported Mar 19, 2026
Fiscal 2025 sales $435.0M Full-year 2025 revenue, down 6.9% year-over-year
Fiscal 2025 net loss $35.9M Includes $20.4M non-cash valuation allowance
Planned revolving facility $75 million Indicative revolving credit facility term sheet referenced in Schedule TO
Combined revenue run-rate $1.2B Targeted combined revenue run-rate with FullBeauty merger

Historical Context

5 past events · Latest: May 14 (Neutral)
Pattern 5 events
Date Event Sentiment 24h Move Catalyst
May 14 Earnings date notice Neutral +7.7% Announcement of upcoming Q1 2026 results and conference call timing.
Mar 19 Earnings results Negative -4.9% Q4 and full-year 2025 sales declines and net loss with merger plans.
Mar 11 Earnings date notice Neutral -2.0% Scheduling announcement for Q4 and fiscal 2025 earnings release.
Jan 12 Holiday sales update Negative -4.2% Holiday sales decline and softer comparable sales, plus merger disclosure.
Dec 11 Earnings results Negative -26.9% Q3 2025 sales decline, net loss, and strategy update with FullBeauty merger.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Earnings and operating updates with weakening fundamentals have often coincided with negative price reactions, while neutral event notices have produced mixed outcomes.

Recent Company History

Over the past six months, Destination XL has reported several operating updates highlighting sales declines and net losses, including Q4 fiscal 2025 sales of $112.1M and a fiscal 2025 net loss of $35.9M. Holiday sales and Q3 results also reflected softer demand. Against this backdrop, the company announced and progressed a merger with FullBeauty targeting ~$1.2B in combined revenue. Today’s unsolicited $0.82 per share tender offer arrives while the Board is already evaluating a strategic transaction with FullBeauty.

Key Terms

tender offer, schedule 14d-9, solicitation/recommendation statement
3 terms
tender offer financial
"unsolicited $0.82 per share in cash tender offer (the “Offer”) made by Zodiac"
A tender offer is a proposal made by a person or company to buy shares from existing shareholders at a set price, usually higher than the current market value, within a specific time frame. It matters to investors because it can lead to a change in ownership or control of a company, and shareholders must decide whether to sell their shares at the offered price.
View in glossary
schedule 14d-9 regulatory
"by filing a Solicitation/Recommendation Statement on Schedule 14D-9 with the U.S."
Schedule 14D-9 is a filing with the U.S. Securities and Exchange Commission in which a company publicly states its response and recommendation to an outside bid to buy its shares (a tender offer). Think of it as the company’s advisory note to shareholders explaining whether to sell, keep, or seek alternatives, and why, with facts and reasoning. Investors rely on it to gauge management’s view of the offer’s fairness and the likely impact on value and strategy.
solicitation/recommendation statement regulatory
"by filing a Solicitation/Recommendation Statement on Schedule 14D-9 with the U.S."
A solicitation/recommendation statement is a public message from a company, board member, shareholder or advisor that asks investors to take a specific action—such as voting a proxy, tendering shares, or accepting or rejecting an offer—and explains which choice the issuer recommends. It matters to investors because these statements aim to shape outcomes that affect ownership, control or value, and they are often subject to disclosure rules so readers can judge the source’s motives and reliability; think of it like a persuasive letter that also must show who wrote it and why.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

No Shareholder Action Required at this Time

CANTON, Mass., May 22, 2026 (GLOBE NEWSWIRE) -- Destination XL Group, Inc. (“DXL”) (NASDAQ: DXLG), the leading integrated commerce retailer of Big + Tall men’s clothing and shoes, today issued the following statement with respect to the unsolicited $0.82 per share in cash tender offer (the “Offer”) made by Zodiac Partners II, LLC ("Zodiac") on May 12, 2026:

The DXL Board of Directors is carefully evaluating the Offer with its independent financial and legal advisors in furtherance of its fiduciary duties and in light of the Company’s merger agreement with FBB Holdings I, Inc. (“FullBeauty”). The Board will make a recommendation to shareholders in due course.

DXL shareholders are advised to take no action at this time pending the Board's review of the Offer.

DXL will advise shareholders of the Board's position regarding the Offer within ten business days of the date of Zodiac’s Offer by filing a Solicitation/Recommendation Statement on Schedule 14D-9 with the U.S. Securities and Exchange Commission (the "SEC"), which will also be published on DXL's investor relations website at investor.dxl.com.

Advisors

Guggenheim Securities, LLC is acting as financial advisor to DXL, Greenberg Traurig, LLP is acting as its legal advisor and Joele Frank, Wilkinson Brimmer Katcher is serving as its strategic communications advisor.

About Destination XL Group, Inc.

Destination XL Group, Inc. is the leading retailer of Men’s Big + Tall apparel that provides the Big + Tall man the freedom to choose his own style. Subsidiaries of Destination XL Group, Inc. operate DXL Big + Tall retail and outlet stores and Casual Male XL retail and outlet stores throughout the United States, and an e-commerce website, DXL.COM, and mobile app, which offer a multi-channel solution similar to the DXL store experience with the most extensive selection of online products available anywhere for Big + Tall men. The Company is headquartered in Canton, Massachusetts, and its common stock is listed on the Nasdaq Global Market under the symbol "DXLG." For more information, please visit the Company's investor relations website: https://investor.dxl.com.

Investor Contact:
Investor.relations@dxlg.com
603-933-0541

Important Information about the Zodiac Tender Offer and Where to Find It

DXL intends to file a solicitation/recommendation statement on Schedule 14D-9 with respect to the tender offer with the Securities and Exchange Commission (the “SEC”) within 10 business days of the commencement of the Zodiac tender offer. INVESTORS AND SECURITY HOLDERS ARE ADVISED TO READ ALL RELEVANT DOCUMENTS FILED WITH THE SEC, INCLUDING THE SOLICITATION/RECOMMENDATION STATEMENT AND ANY OTHER RELEVANT DOCUMENTS WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE TENDER OFFER. Investors and security holders may obtain free copies of the solicitation/recommendation statement (when available) as well as other filings by DXL, without charge, at the SEC’s website, http://www.sec.gov, or by accessing DXL’s website at investor.dxl.com. In addition, documents filed with the SEC by DXL will be available free of charge by writing to DXL at 555 Turnpike Street, Canton, Massachusetts 02021, Attention: Corporate Secretary.

Important Information about the Merger and Where to Find It

This communication does not constitute an offer to sell or the solicitation of an offer to buy any securities or a solicitation of any vote or approval. This communication may be deemed to be solicitation material in respect of the proposed merger (the “Merger”) between DXL and FullBeauty. In connection with the Merger, DXL intends to file a proxy statement (the “Proxy Statement”), which will be distributed to the stockholders of DXL in connection with their votes on the issuance of DXL Common Stock in the Merger. INVESTORS AND SECURITY HOLDERS ARE ADVISED TO READ THE PROXY STATEMENT WHEN IT BECOMES AVAILABLE (AND ANY OTHER DOCUMENTS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION (THE “SEC”) IN CONNECTION WITH THE MERGER OR INCORPORATED BY REFERENCE INTO THE PROXY STATEMENT) BECAUSE SUCH DOCUMENTS WILL CONTAIN IMPORTANT INFORMATION REGARDING THE MERGER AND RELATED MATTERS. Investors and security holders will be able to obtain these documents, and any other documents DXL has filed with the SEC, free of charge at the SEC’s website, www.sec.gov, or by accessing DXL’s website at investor.dxl.com. In addition, documents filed with the SEC by DXL will be available free of charge by writing to DXL at 555 Turnpike Street, Canton, Massachusetts 02021, Attention: Corporate Secretary.

Participants in the Solicitation

DXL and certain of its directors and executive officers may be deemed to be participants in the solicitation of proxies from the stockholders of DXL in connection with the Merger. Information about DXL’s directors and executive officers, including a description of their direct or indirect interests, by security holdings or otherwise, is set forth in DXL’s proxy statement for its 2025 annual meeting of stockholders, which was filed with the SEC on June 30, 2025, including under the headings “Director Compensation,” “Compensation Discussion and Analysis,” “Executive Compensation,” “Security Ownership of Management.” To the extent holdings of DXL Common Stock by the directors and executive officers of DXL have changed from the amounts of DXL Common Stock held by such persons as reflected therein, such changes have been or will be reflected on Initial Statements of Beneficial Ownership of Securities on Form 3, Statements of Changes in Beneficial Ownership on Form 4 or Annual Statements of Changes in Beneficial Ownership of Securities on Form 5, in each case filed with the SEC, including the Form 4s filed by each of the non-executive directors on August 6, 2025, the Form 4s filed by each of the executive officers on September 3, 2025 and the Form 4s filed by each of the non-executive directors on November 5, 2025.

FBB and its chief executive officer may be deemed to be participants in the solicitation of proxies from the stockholders of DXL in connection with the Merger. Information about FBB and its chief executive officer can be found in the Form 8-K filed by DXL with the SEC on December 11, 2025.

Additional information regarding the participants in the proxy solicitation and a description of their direct and indirect interests, by security holdings or otherwise, will be contained in the Proxy Statement regarding the Merger when it becomes available. Free copies of this document may be obtained as described above.

Forward-Looking Statements

In addition to historical information, this document contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements, including statements as to the expected timing, are based on current expectations, estimates and beliefs of DXL management. Words such as “anticipates,” “believes,” “estimates,” “expects,” “intends,” “plans,” “seeks” and variations of such words and similar expressions are intended to identify such forward-looking statements, which generally are not historical in nature. With respect to any such forward-looking statements, DXL claims the protection provided for in the Private Securities Litigation Reform Act of 1995. Although we believe the expectations reflected in any forward-looking statements are based on reasonable assumptions, we can give no assurance that our expectations will be attained and therefore, actual outcomes and results may differ materially from what is expressed or forecasted in such forward-looking statements. These forward-looking statements could be affected by factors including, without limitation, the risks and factors detailed in reports filed with the SEC by DXL from time to time, including those discussed under the heading “Risk Factors” in DXL’s most recently filed Annual Report on Form 10-K. These documents are available through our website or through the SEC’s Electronic Data Gathering and Analysis Retrieval (EDGAR) system at http://www.sec.gov. Neither DXL undertakes any duty to update any forward-looking statements contained herein, whether as a result of new information or developments, future events or otherwise, except as required by law. Readers are cautioned not to place undue reliance on any of these forward-looking statements.


FAQ

What unsolicited tender offer did Destination XL Group (DXLG) receive in May 2026?

Destination XL Group received an unsolicited cash tender offer of $0.82 per share from Zodiac Partners II on May 12, 2026. According to DXL, the board is evaluating this offer with independent financial and legal advisors before issuing a recommendation.

How is Destination XL Group's board responding to Zodiac Partners II's tender offer for DXLG shares?

DXL’s board is carefully evaluating Zodiac’s $0.82 per share tender offer with independent financial and legal advisors. According to DXL, the review considers the existing merger agreement with FullBeauty, and a formal recommendation will follow in a Schedule 14D-9 filing.

Should Destination XL Group (DXLG) shareholders take action on the Zodiac tender offer now?

DXL advises shareholders to take no action at this time regarding Zodiac’s tender offer. According to DXL, investors should wait for the board’s recommendation, which will be provided in a Schedule 14D-9 filing within ten business days of the offer date.

When will Destination XL Group (DXLG) issue its recommendation on the Zodiac tender offer?

DXL plans to publish its recommendation within ten business days of Zodiac’s May 12, 2026 offer. According to DXL, this guidance will appear in a Schedule 14D-9 filing with the SEC and on the company’s investor relations website.

How does the Zodiac tender offer affect Destination XL Group's merger with FullBeauty?

The board is evaluating Zodiac’s $0.82 per share offer in light of its merger agreement with FullBeauty. According to DXL, this review is part of the board’s fiduciary duties, and details will be included in the upcoming Schedule 14D-9 recommendation.

Who is advising Destination XL Group (DXLG) on the Zodiac tender offer review?

DXL has engaged Guggenheim Securities as financial advisor and Greenberg Traurig as legal advisor. According to DXL, Joele Frank, Wilkinson Brimmer Katcher is providing strategic communications advice during the board’s review of the unsolicited tender offer.